Ben Ray Lujan on Drugs

Remove marijuana from the Controlled Substances Act

"We recognize and appreciate DEA's effort to address the flaws in our current marijuana policy by using its authority under the CSA and following the scientific and medical evidence to reschedule marijuana as a Schedule III drug," the letter continues. "We urge DEA to finalize the rule."

The letter's signatories from the Senate are:
• Cory Booker, D-NJ
• Ron Wyden, D-OR
• Tina Smith, D-MN
• Ben Ray Lujan, D-NM
• Patty Murray, D-WA
• Kirsten Gillibrand, D-NY

Co-sponsored federal decriminalization of marijuana bill

Ben Ray Lujan: Decriminalize. Co-sponsored bill to federally decriminalize. Pushed bill to remove marijuana as a deportable offense.

Mark Ronchetti: No position found.

Change approach to minor non-violent marijuana arrests

Hold opioid manufacturers accountable for role in epidemic

Rated B by NORML, indicating a pro-drug-reform stance.

OnTheIssues.org interprets the 2016 NORML scores as follows:

• C-/D/F: `hard-on-drugs` stance (approx. 243 members)
• C: mixed record on drug reform (approx. 45 members)
• A/B: pro-drug-reform stance (approx. 293 members)

National Organization for the Reform of Marijuana Law`s mission is to move public opinion sufficiently to achieve the repeal of marijuana prohibition so that the responsible use of cannabis by adults is no longer subject to penalty.

NORML is a nonprofit, public-interest lobby that for more than 30 years has provided a voice for those Americans who oppose marijuana prohibition. We represent the interests of the tens of millions of Americans who smoke marijuana responsibly and believe the recreational and medicinal use of marijuana should no longer be a crime.

NORML supports the removal of all criminal penalties for the private possession & responsible use of marijuana by adults, including the cultivation for personal use, and the casual nonprofit transfers of small amounts. This model is called `decriminalization.`

NORML additionally supports the development of a legally controlled market for marijuana, where consumers could purchase it from a safe, legal and regulated source. This model is referred to as `legalization.`

NORML believes that marijuana smoking is not for kids and should only be used responsibly by adults. As with alcohol consumption, it must never be an excuse for misconduct or other bad behavior. Driving or operating heavy equipment while impaired from marijuana should be prohibited.

NORML strongly supports the right of patients to use marijuana as a medicine when their physician recommends it to relieve pain and suffering.

Lastly, NORML supports the right of farmers to commercially cultivate hemp for industrial purposes, such as food and fiber production.

Voted NO on additional Drug War funding for synthetic drugs.

GovTrack.us Summary: (SITSA): There are more than 400 known types of synthetic--or `artificial`--drugs, which mimic the effects of substances including cocaine and ecstasy. They`ve largely begun to flood the market in recent years. The bill outlaws 13 different synthetic drugs of the most pernicious varieties. There are more than 400 known types of synthetic--or `artificial`--drugs, which mimic the effects of substances including cocaine and ecstasy. They`ve largely begun to flood the market in recent years.

GovTrack Pro/Con: Supporters argue the legislation will tackle a growing scourge in a far more timely and immediate manner than what the lagging DEA is usually able to accomplish. Opponents argue the bill would too greatly expand Attorney General Jeff Sessions` ability to criminalize drugs and impose unnecessarily punitive mandatory sentences, according to a letter signed by dozens of organizations including the American Civil Liberties Union (ACLU), Human Rights Watch, and NAACP.Opponent`s argument to vote NO Rep. Jerrold Nadler (D-NY): The bill would explicitly impose mandatory minimum terms of supervised release which undermines the discretion of judges who are in the best position to make such determinations based on the facts and circumstances of each case.

Legislative outcome: House Bill Passed 239-142-46, Roll Number 268 on June 15, 2018